PT3225233T - Solução de cloreto de sódio para reconstituição de fármacos. - Google Patents

Solução de cloreto de sódio para reconstituição de fármacos.

Info

Publication number: PT3225233T
Authority: PT; Portugal
Prior art keywords: sodium chloride; chloride solution; drug reconstitution; reconstitution; drug
Prior art date: 2005-11-01

Application number

PT171666167T

Other languages

English (en)

Inventor

A Webb Chandra

Zerfas Julie

Original Assignee

Wyeth Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-01

Filing date

2006-10-27

Publication date

2019-10-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37801586&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3225233(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-10-27 Application filed by Wyeth Llc filed Critical Wyeth Llc

2019-10-24 Publication of PT3225233T publication Critical patent/PT3225233T/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oil, Petroleum & Natural Gas (AREA)
Inorganic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PT171666167T 2005-11-01 2006-10-27 Solução de cloreto de sódio para reconstituição de fármacos. PT3225233T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US73222105P	2005-11-01	2005-11-01

Publications (1)

Publication Number	Publication Date
PT3225233T true PT3225233T (pt)	2019-10-24

Family

ID=37801586

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT171666167T PT3225233T (pt)	2005-11-01	2006-10-27	Solução de cloreto de sódio para reconstituição de fármacos.
PT68270362T PT1942868T (pt)	2005-11-01	2006-10-27	Solução de cloreto de sódio para reconstituição ou diluição de fármacos

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PT68270362T PT1942868T (pt)	2005-11-01	2006-10-27	Solução de cloreto de sódio para reconstituição ou diluição de fármacos

Country Status (31)

Country	Link
US (4)	US20070135343A1 (pt)
EP (3)	EP3225233B1 (pt)
JP (1)	JP5555425B2 (pt)
KR (2)	KR101126670B1 (pt)
CN (1)	CN101351190B (pt)
AR (2)	AR056748A1 (pt)
AU (1)	AU2006308921C1 (pt)
BR (1)	BRPI0618133A2 (pt)
CA (1)	CA2626531C (pt)
CR (1)	CR9958A (pt)
DK (2)	DK1942868T5 (pt)
EC (1)	ECSP088485A (pt)
ES (2)	ES2749574T3 (pt)
FI (1)	FI1942868T4 (pt)
FR (1)	FR20C1005I1 (pt)
GT (1)	GT200800037A (pt)
HK (1)	HK1245090B (pt)
HU (4)	HUE033949T2 (pt)
IL (1)	IL190843A (pt)
LU (1)	LUC00035I2 (pt)
MY (1)	MY184364A (pt)
NO (1)	NO347263B1 (pt)
NZ (1)	NZ567685A (pt)
PE (3)	PE20151284A1 (pt)
PL (2)	PL3225233T3 (pt)
PT (2)	PT3225233T (pt)
RU (1)	RU2432157C2 (pt)
SI (2)	SI1942868T2 (pt)
TW (1)	TWI480063B (pt)
UA (1)	UA97234C2 (pt)
WO (1)	WO2007053533A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3225233B1 (en)	2005-11-01	2019-08-14	Wyeth LLC	Sodium chloride solution for drug reconstitution
US7767206B2 (en)	2006-10-02	2010-08-03	Amgen Inc.	Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
US8431011B2 (en)	2008-01-31	2013-04-30	Abbott Diabetes Care Inc.	Method for automatically and rapidly distinguishing between control and sample solutions in a biosensor strip
CA2780554C (en) *	2009-11-17	2017-08-15	Ipsen Pharma S.A.S.	Formulation for hgh and rhigf-1 combination
US9427186B2 (en)	2009-12-04	2016-08-30	Endomagnetics Ltd.	Magnetic probe apparatus
US10634741B2 (en)	2009-12-04	2020-04-28	Endomagnetics Ltd.	Magnetic probe apparatus
WO2011088120A1 (en)	2010-01-15	2011-07-21	Amgen Inc.	Antibody formulation and therapeutic regimens
JP5937523B2 (ja) *	2010-03-01	2016-06-22	サイトダインインコーポレイテッドＣｙｔｏＤｙｎ，Ｉｎｃ．	濃縮されたタンパク質製剤およびその使用
NZ605348A (en)	2010-07-09	2015-01-30	Biogen Idec Hemophilia Inc	Factor ix polypeptides and methods of use thereof
TWI810729B (zh) *	2012-09-25	2023-08-01	美商百歐維拉提夫治療公司	Ｆｉｘ多肽的應用
CA2904779C (en)	2013-03-11	2019-04-09	Endomagnetics Ltd.	Hypoosmotic solutions for lymph node detection
US9234877B2 (en)	2013-03-13	2016-01-12	Endomagnetics Ltd.	Magnetic detector
US9239314B2 (en)	2013-03-13	2016-01-19	Endomagnetics Ltd.	Magnetic detector
WO2014144549A1 (en) *	2013-03-15	2014-09-18	Biogen Idec Ma Inc.	Factor ix polypeptide formulations
FR3005420B1 (fr)	2013-05-07	2015-09-18	Erytech Pharma	Procede de stabilisation de suspensions d'erythrocytes encapsulant un principe actif, suspensions obtenues.
SG10201913735SA (en) *	2014-03-24	2020-03-30	Bioverativ Therapeutics Inc	Lyophilized factor ix formulations
US9351945B1 (en)	2015-02-27	2016-05-31	John Daniel Dobak, III	Reduction of adipose tissue
GB2536703B (en) *	2015-03-27	2020-12-02	Ge Healthcare Bio Sciences Ab	Method for baseline correction in a chromatogram
EP3081942A1 (en) *	2015-04-17	2016-10-19	Roche Diagniostics GmbH	Pressure transmission liquid for cellular analyzer, cellular analyzer and method for analyzing a liquid cellular sample
ES2833377T3 (es)	2015-06-04	2021-06-15	Endomagnetics Ltd	Materiales marcadores y formas de localizar un marcador magnético
US10124021B2 (en) *	2016-12-23	2018-11-13	Andrew L. Gostine	Intravenous fluid
EP3694322B1 (en)	2017-10-09	2024-07-03	Terumo BCT Biotechnologies, LLC	Lyophilization container and method of using same
EP3938741B1 (en)	2019-03-14	2024-05-01	Terumo BCT Biotechnologies, LLC	Lyophilization container fill fixture, system and method of use
US12036187B2 (en) *	2019-05-01	2024-07-16	Southwest Research Institute	Compositions of dimethyl trisulfide (DMTS) as a cyanide antidote
WO2021108051A2 (en) *	2019-10-25	2021-06-03	Cmc Pharmaceuticals, Inc.	Atropine-scopolamine with enhanced stability
IL272145A (en) *	2020-01-20	2021-07-29	Stem Cell Medicine Ltd	Cosmetic preparations with protein concentrate from a conditioned growth medium of stem cells from adipose tissue
EP4175698A4 (en) *	2020-08-03	2024-07-31	Transluminal Systems, LLC	DEVICES AND METHODS FOR ARTERIAL OSMOTIC EMBOLIZATION OF PATHOLOGICAL TISSUES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3717708A (en) *	1968-10-24	1973-02-20	Cutter Lab	Blood coagulation complex
US4364861A (en)	1980-05-27	1982-12-21	Cutter Laboratories, Inc.	Blood-coagulation-promoting products and methods of preparing them
US6372716B1 (en)	1994-04-26	2002-04-16	Genetics Institute, Inc.	Formulations for factor IX
EP2193809B1 (en)	1999-02-22	2015-04-08	University of Connecticut	Albumin-free factor VIII formulations
US20010031721A1 (en) *	1999-05-05	2001-10-18	Chandra Webb	Highly concentrated, lyophilized, and liquid factor IX formulations
IL155002A0 (en) *	2000-10-12	2003-10-31	Genentech Inc	Reduced-viscosity concentrated protein formulations
KR20140093711A (ko)	2003-12-19	2014-07-28	노보 노르디스크 헬스 케어 악티엔게젤샤프트	인자 ｖｉｉ 폴리펩티드의 안정화된 조성물
CA2554018A1 (en) *	2004-03-04	2005-09-29	Wyeth	Lyophilization method to improve excipient crystallization
EP3225233B1 (en)	2005-11-01	2019-08-14	Wyeth LLC	Sodium chloride solution for drug reconstitution

2006
- 2006-10-27 EP EP17166616.7A patent/EP3225233B1/en not_active Revoked
- 2006-10-27 TW TW095139724A patent/TWI480063B/zh active
- 2006-10-27 RU RU2008119514/15A patent/RU2432157C2/ru active
- 2006-10-27 CA CA2626531A patent/CA2626531C/en active Active
- 2006-10-27 NO NO20082180A patent/NO347263B1/no unknown
- 2006-10-27 JP JP2008538945A patent/JP5555425B2/ja active Active
- 2006-10-27 PL PL17166616T patent/PL3225233T3/pl unknown
- 2006-10-27 AU AU2006308921A patent/AU2006308921C1/en active Active
- 2006-10-27 EP EP19189599.4A patent/EP3593790A1/en not_active Withdrawn
- 2006-10-27 PE PE2015001729A patent/PE20151284A1/es not_active Application Discontinuation
- 2006-10-27 PL PL06827036.2T patent/PL1942868T5/pl unknown
- 2006-10-27 DK DK06827036.2T patent/DK1942868T5/da active
- 2006-10-27 EP EP06827036.2A patent/EP1942868B2/en active Active
- 2006-10-27 PE PE2011000653A patent/PE20110803A1/es not_active Application Discontinuation
- 2006-10-27 ES ES17166616T patent/ES2749574T3/es active Active
- 2006-10-27 PT PT171666167T patent/PT3225233T/pt unknown
- 2006-10-27 ES ES06827036T patent/ES2627684T5/es active Active
- 2006-10-27 MY MYPI20081347A patent/MY184364A/en unknown
- 2006-10-27 CN CN2006800400807A patent/CN101351190B/zh active Active
- 2006-10-27 US US11/589,002 patent/US20070135343A1/en not_active Abandoned
- 2006-10-27 PT PT68270362T patent/PT1942868T/pt unknown
- 2006-10-27 KR KR1020087013252A patent/KR101126670B1/ko active Active
- 2006-10-27 BR BRPI0618133-3A patent/BRPI0618133A2/pt not_active Application Discontinuation
- 2006-10-27 WO PCT/US2006/042258 patent/WO2007053533A2/en not_active Ceased
- 2006-10-27 HU HUE06827036A patent/HUE033949T2/hu unknown
- 2006-10-27 SI SI200632172T patent/SI1942868T2/sl unknown
- 2006-10-27 KR KR1020117027131A patent/KR20110128957A/ko not_active Withdrawn
- 2006-10-27 PE PE2006001318A patent/PE20070714A1/es not_active Application Discontinuation
- 2006-10-27 SI SI200632348T patent/SI3225233T1/sl unknown
- 2006-10-27 UA UAA200807432A patent/UA97234C2/ru unknown
- 2006-10-27 DK DK17166616.7T patent/DK3225233T3/da active
- 2006-10-27 HU HUE17166616A patent/HUE045421T2/hu unknown
- 2006-10-27 NZ NZ567685A patent/NZ567685A/en unknown
- 2006-10-31 AR ARP060104769A patent/AR056748A1/es not_active Application Discontinuation
2008
- 2008-04-14 IL IL190843A patent/IL190843A/en active IP Right Grant
- 2008-04-17 GT GT200800037A patent/GT200800037A/es unknown
- 2008-05-07 CR CR9958A patent/CR9958A/es not_active Application Discontinuation
- 2008-05-30 EC EC2008008485A patent/ECSP088485A/es unknown
2016
- 2016-10-07 US US15/288,860 patent/US20170021022A1/en not_active Abandoned
2017
- 2017-09-25 LU LU00035C patent/LUC00035I2/fr unknown
- 2017-09-27 HU HUS1700035C patent/HUS1700035I1/hu unknown
2018
- 2018-04-04 HK HK18104477.4A patent/HK1245090B/en unknown
- 2018-07-06 AR ARP180101902 patent/AR112443A2/es not_active Application Discontinuation
2019
- 2019-12-20 US US16/723,563 patent/US20200138952A1/en not_active Abandoned
2020
- 2020-01-31 HU HUS2000003C patent/HUS2000003I1/hu unknown
- 2020-02-10 FR FR20C1005C patent/FR20C1005I1/fr active Active
- 2020-07-14 US US16/946,998 patent/US20200338199A1/en not_active Abandoned
2023
- 2023-03-17 FI FIEP06827036.2T patent/FI1942868T4/fi active

Also Published As

Publication number	Publication date
HUE045421T2 (hu)	2019-12-30
US20170021022A1 (en)	2017-01-26
AR056748A1 (es)	2007-10-24
CR9958A (es)	2008-07-29
ECSP088485A (es)	2008-06-30
PL1942868T5 (pl)	2023-12-27
CA2626531C (en)	2011-11-29
WO2007053533A8 (en)	2008-07-24
SI1942868T2 (sl)	2023-12-29
WO2007053533A2 (en)	2007-05-10
SI1942868T1 (sl)	2017-07-31
EP3225233B1 (en)	2019-08-14
CA2626531A1 (en)	2007-05-10
FR20C1005I1 (fr)	2020-03-20
PE20070714A1 (es)	2007-07-20
DK1942868T5 (da)	2024-01-08
EP1942868B1 (en)	2017-04-19
AU2006308921A1 (en)	2007-05-10
EP3593790A1 (en)	2020-01-15
HUS1700035I1 (hu)	2017-11-28
HUS2000003I1 (hu)	2020-02-28
FI1942868T4 (fi)	2023-10-12
KR20080065689A (ko)	2008-07-14
EP3225233A1 (en)	2017-10-04
ES2749574T3 (es)	2020-03-23
KR101126670B1 (ko)	2012-04-23
PL1942868T3 (pl)	2017-09-29
TW200803915A (en)	2008-01-16
US20070135343A1 (en)	2007-06-14
AU2006308921B2 (en)	2012-07-19
AR112443A2 (es)	2019-10-30
JP2009513705A (ja)	2009-04-02
ES2627684T5 (es)	2024-04-29
EP1942868B2 (en)	2023-10-04
NO20082180A (no)	2008-07-04
NZ567685A (en)	2011-07-29
US20200138952A1 (en)	2020-05-07
AU2006308921C1 (en)	2013-01-24
SI3225233T1 (sl)	2019-10-30
JP5555425B2 (ja)	2014-07-23
PL3225233T3 (pl)	2019-12-31
IL190843A0 (en)	2008-11-03
KR20110128957A (ko)	2011-11-30
HUE033949T2 (hu)	2018-01-29
WO2007053533A3 (en)	2007-12-06
TWI480063B (zh)	2015-04-11
CN101351190B (zh)	2013-01-02
DK1942868T4 (da)	2023-11-06
PE20110803A1 (es)	2011-11-07
PT1942868T (pt)	2017-06-16
RU2008119514A (ru)	2009-12-10
CN101351190A (zh)	2009-01-21
LUC00035I1 (pt)	2017-09-28
DK1942868T3 (en)	2017-06-26
NO347263B1 (no)	2023-08-14
UA97234C2 (ru)	2012-01-25
RU2432157C2 (ru)	2011-10-27
ES2627684T3 (es)	2017-07-31
MY184364A (en)	2021-04-01
NO20082180L (no)	2008-07-04
US20200338199A1 (en)	2020-10-29
DK3225233T3 (da)	2019-10-14
LUC00035I2 (pt)	2017-12-01
BRPI0618133A2 (pt)	2011-08-16
IL190843A (en)	2013-08-29
PE20151284A1 (es)	2015-10-05
HK1245090B (en)	2020-04-09
GT200800037A (es)	2008-10-01
EP1942868A2 (en)	2008-07-16

Publication	Publication Date	Title
HUS2000003I1 (hu)	2020-02-28	Nátrium klorid oldat gyógyszer újraoldására
IL191907A0 (en)	2008-12-29	Azepinoindole derivatives as pharmaceutical agents
GB0501999D0 (en)	2005-03-09	Pharmaceutical compounds
GB0520657D0 (en)	2005-11-16	Pharmaceutical compounds
ZA200801275B (en)	2008-12-31	Pharmaceutical preparation containing meloxicam
GB0520656D0 (en)	2005-11-16	Pharmaceutical compounds
IL188438A0 (en)	2008-11-03	New pharmaceutical compounds
EP1776112A4 (en)	2009-11-25	HETEROCYCLIC COMPOUNDS AS PHARMACEUTICAL AGENTS
EP1852117A4 (en)	2010-10-27	PHARMACEUTICAL AGENT COMPRISING SOLIFENACIN
GB0512643D0 (en)	2005-07-27	Pharmaceutical compounds
ZA200800515B (en)	2008-12-31	New Salt I
EP1871344A4 (en)	2012-05-02	INHIBITABLE MEDICINAL PRODUCT
ZA200705612B (en)	2009-09-30	Pharmaceutical compounds
GB0501475D0 (en)	2005-03-02	Pharmaceutical compounds
GB0515315D0 (en)	2005-08-31	Pharmaceutical agents
GB0514530D0 (en)	2005-08-24	Pharmaceutical agent
GB0501729D0 (en)	2005-03-02	Pharmaceutical compounds
GB0510252D0 (en)	2005-06-29	Pharmaceutical compounds
GB0501480D0 (en)	2005-03-02	Pharmaceutical compounds
GB0501998D0 (en)	2005-03-09	Pharmaceutical compounds
GB0507474D0 (en)	2005-05-18	Pharmaceutical compounds
GB0512642D0 (en)	2005-07-27	Pharmaceutical compounds
GB0512654D0 (en)	2005-07-27	Pharmaceutical compounds
GB0501310D0 (en)	2005-03-02	Pharmaceutical compounds
GB0501748D0 (en)	2005-03-02	Pharmaceutical compounds